🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/03/2003 | 23,84 | 25,83 | 23,21 | 24,29 | +1,41% | 10,99% | 188.112 |
| 28/03/2003 | 23,47 | 24,33 | 23,36 | 23,96 | +2,40% | 4,15% | 284.132 |
| 27/03/2003 | 23,13 | 23,43 | 22,65 | 23,39 | +1,63% | 3,40% | 68.448 |
| 26/03/2003 | 23,36 | 23,62 | 22,83 | 23,02 | -0,81% | 3,37% | 93.562 |
| 25/03/2003 | 21,71 | 23,21 | 21,63 | 23,21 | +6,16% | 7,24% | 197.890 |
| 24/03/2003 | 21,52 | 22,42 | 21,22 | 21,86 | -2,34% | 5,57% | 97.088 |
| 21/03/2003 | 21,48 | 22,46 | 21,11 | 22,38 | +7,75% | 6,27% | 163.827 |
| 20/03/2003 | 21,15 | 21,52 | 20,47 | 20,77 | -2,63% | 4,96% | 161.876 |
| 19/03/2003 | 20,74 | 22,35 | 20,40 | 21,34 | +2,33% | 9,39% | 124.954 |
| 18/03/2003 | 21,56 | 21,90 | 20,32 | 20,85 | -2,79% | 7,29% | 363.614 |
| 17/03/2003 | 20,59 | 22,42 | 20,55 | 21,45 | +2,87% | 9,09% | 350.336 |
| 14/03/2003 | 20,36 | 21,45 | 20,36 | 20,85 | +4,50% | 5,33% | 195.192 |
| 13/03/2003 | 19,20 | 20,51 | 18,90 | 19,95 | +7,68% | 8,38% | 264.041 |
| 12/03/2003 | 17,82 | 18,64 | 17,78 | 18,53 | +3,77% | 4,83% | 287.578 |
| 11/03/2003 | 17,18 | 17,85 | 16,99 | 17,85 | +3,70% | 5,01% | 119.530 |
| 10/03/2003 | 17,29 | 17,29 | 16,73 | 17,22 | +1,10% | 3,25% | 98.157 |
| 07/03/2003 | 16,73 | 17,74 | 16,73 | 17,03 | +0,89% | 6,04% | 48.624 |
| 06/03/2003 | 17,26 | 17,26 | 16,66 | 16,88 | -2,59% | 3,47% | 49.212 |
| 05/03/2003 | 17,33 | 17,40 | 16,66 | 17,33 | +0,65% | 4,32% | 51.964 |
| 04/03/2003 | 17,40 | 17,78 | 16,84 | 17,22 | -1,08% | 5,38% | 56.452 |
| 03/03/2003 | 17,78 | 18,27 | 17,33 | 17,40 | -1,69% | 5,26% | 118.756 |
| 28/02/2003 | 16,81 | 17,89 | 16,32 | 17,70 | +6,05% | 9,35% | 278.468 |
| 27/02/2003 | 16,58 | 16,84 | 16,06 | 16,69 | +1,13% | 4,74% | 433.986 |
| 26/02/2003 | 17,44 | 17,44 | 16,39 | 16,51 | -4,96% | 6,01% | 261.690 |
| 25/02/2003 | 17,52 | 17,74 | 16,58 | 17,37 | -3,33% | 6,62% | 562.600 |
| 24/02/2003 | 16,84 | 18,38 | 16,09 | 17,97 | +7,86% | 13,56% | 450.390 |
| 21/02/2003 | 15,23 | 18,49 | 14,86 | 16,66 | +12,66% | 23,83% | 289.716 |
| 20/02/2003 | 15,12 | 15,12 | 14,30 | 14,78 | -0,75% | 5,45% | 67.513 |
| 19/02/2003 | 14,67 | 15,16 | 14,60 | 14,90 | +2,05% | 3,83% | 207.054 |
| 18/02/2003 | 14,71 | 15,31 | 14,37 | 14,60 | +1,04% | 6,36% | 106.920 |